Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-11

Clinical Trial Update: Pain Sensitivity in NREM Parasomnia (NOCISOMNIE) [NA]

View source ↗

Summary

The NOCISOMNIE trial evaluating pain sensitivity in NREM parasomnia has been withdrawn. Conditions include NREM parasomnia, sleepwalking, and sleep terror.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Montpellier | Conditions: NREM Parasomnia, Sleepwalking | NA | Status: WITHDRAWN